Nektar Therapeutics
(NASDAQ : NKTR)

( )
NKTR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.21%202.771.2%$538.23m
GILDGilead Sciences, Inc.
-0.90%75.620.9%$479.42m
BIIBBiogen Inc.
-0.11%338.231.3%$390.35m
CELGCelgene Corporation
0.00%84.281.2%$342.66m
ILMNIllumina, Inc.
0.73%328.963.5%$326.50m
REGNRegeneron Pharmaceuticals, Inc.
0.14%399.062.6%$241.66m
ALXNAlexion Pharmaceuticals, Inc.
0.97%128.942.0%$225.63m
VRTXVertex Pharmaceuticals Incorporated
0.02%185.481.9%$218.83m
SRPTSarepta Therapeutics, Inc.
2.46%141.9916.4%$179.98m
AAgilent Technologies, Inc.
-0.37%67.211.5%$160.39m
BMRNBioMarin Pharmaceutical Inc.
0.06%106.074.4%$146.21m
LGNDLigand Pharmaceuticals Incorporated
-3.73%203.0123.3%$122.43m
VKTXViking Therapeutics, Inc.
-2.62%14.860.9%$115.47m
NKTRNektar Therapeutics
0.24%50.595.6%$107.97m
EXASExact Sciences Corporation
-2.06%66.0525.3%$105.10m

Company Profile

Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms. It operates through the United States and Europe geogrpahical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.